June Sherie Almenoff - 28 Mar 2025 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role: Director
Signature: /s/ Donald R. Reynolds, by Power of Attorney
Issuer symbol: AVTX
Transactions as of: 28 Mar 2025
Net transactions value: $0
Form type: 4
Filing time: 01 Apr 2025, 16:22:37 UTC
Previous filing: 12 Dec 2024
Next filing: 02 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AVTX	Common Stock	Options Exercise		+3,167			3,167	28 Mar 2025	Direct	F1
holding	AVTX	Common Stock						1,000	28 Mar 2025	By Meadowlark Management, LLC	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AVTX	Restricted Stock Units	Options Exercise	$0	-3,167	-33%	$0.000000	6,333	28 Mar 2025	Common Stock	3,167		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
F3	On August 13, 2024, the Reporting Person was granted 9,500 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date.